Prolonged Use of Bevacizumab May Cause Extensive Coronary Artery Thrombosis
dc.contributor.author | Muallaoglu, S. | |
dc.contributor.author | Disel, U. | |
dc.contributor.author | Tekin, A. | |
dc.contributor.author | Mertsoylu, H. | |
dc.contributor.author | Abali, H. | |
dc.contributor.author | Ozyilkan, O. | |
dc.contributor.orcID | https://orcid.org/0000-0002-6242-2802 | en_US |
dc.contributor.orcID | https://orcid.org/0000-0002-5658-870X | en_US |
dc.contributor.orcID | https://orcid.org/0000-0002-1932-9784 | en_US |
dc.contributor.orcID | https://orcid.org/0000-0001-5596-0920 | en_US |
dc.contributor.orcID | https://orcid.org/0000-0001-8825-4918 | en_US |
dc.contributor.pubmedID | 24965427 | en_US |
dc.contributor.researcherID | IVU-7523-2023 | en_US |
dc.contributor.researcherID | ABD-7304-2021 | en_US |
dc.contributor.researcherID | M-9530-2014 | en_US |
dc.contributor.researcherID | D-7660-2016 | en_US |
dc.contributor.researcherID | AAD-2817-2021 | en_US |
dc.date.accessioned | 2024-02-07T13:06:53Z | |
dc.date.available | 2024-02-07T13:06:53Z | |
dc.date.issued | 2014 | |
dc.identifier.endpage | 579 | en_US |
dc.identifier.issn | 1107-0625 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopus | 2-s2.0-84904200206 | en_US |
dc.identifier.startpage | 578 | en_US |
dc.identifier.uri | http://hdl.handle.net/11727/11461 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | 000338407700040 | en_US |
dc.language.iso | eng | en_US |
dc.relation.journal | JOURNAL OF BUON | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | CANCER-PATIENTS | en_US |
dc.subject | ISCHEMIA | en_US |
dc.subject | RISK | en_US |
dc.title | Prolonged Use of Bevacizumab May Cause Extensive Coronary Artery Thrombosis | en_US |
dc.type | letter | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: